SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: John Locke (HR-EN001)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 17judgment calls in the dossier
- 2protocol deviations
- 1orders and referrals without results in the record
- 2evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the decision of asthma with persistent airflow limitation over COPD from non-tobacco exposures, the spirometry interpretation (GLI race-neutral equations, ATS/ERS 2022 bronchodilator criterion), the choice of medium-dose MART and add-on tiotropium, the CT indication, the exposure advice, and the management of the viral flare. |
| provenance review | not_started | | | The Stanford Encyclopedia of Philosophy, the Dictionary of National Biography (1893), Fox Bourne's two-volume biography (1876) quoting his letters and Lady Masham's account, Williams (2006), and Anstey and Principe (2011) logged. The de Beer edition of the correspondence, Woolhouse's biography, Dewhurst's medical biography, and the Bodleian manuscripts could not be read. |
| safe messaging review | not_started | | | No behavioral-health content; PHQ-2 negative at both screens. |
Judgment calls (dossier editorial resolutions)
- Calendar and dates. England used the Julian (Old Style) calendar throughout his life, with the legal year beginning on 25 March. He was born on 29 August 1632 (Julian), which is 8 September 1632 in the Gregorian calendar, and died on 28 October 1704 (Julian), which is 8 November 1704 (Gregorian); the difference was ten days until February 1700 and eleven after. Every documented date is converted to the Gregorian calendar for the true frame, checked by computing Julian day numbers in the build script; the preferred birth and death dates are Gregorian, with the Julian dates recorded as superseded alternatives, and timeline displays give both. Years written “1691-2” in the sources are given as 1691/2 (Julian) and their Gregorian equivalent. Fox Bourne's dates for letters written from Oates are taken as Julian; Limborch, in Amsterdam, may have dated his own letters in the Gregorian calendar, and none of his dates is used.
- Index age and dates. The episode presents him at 59, at Oates, in March 1692, two days after his documented letter of 29 February 1691/2 (Julian; 10 March 1692, Gregorian) saying that his lungs could not bear the smoke of the city. The synthetic date of birth is September 8, 1966, so the whole-year shift is 334 years and 2026 maps to 1692. The visits are March 12 (index), March 26 (diagnosis and consultation), June 18 (twelve-week review), September 17 (preventive visit, at 60), October 8 (sick visit), and October 22, 2026; in the true frame these fall between 12 March and 22 October 1692 (Gregorian), all within his lifetime, while he lived at Oates. His documented visit to Cambridge in May 1692 falls between visits, and his documented London trip of late November 1692 falls after the episode. He is 59 at the first three visits and 60 at the last three.
- Name and mentions. “John Locke” splits simply into given and family names, so `identity.name_parts` is not used, and no alias is recorded. Isaac Newton (HR-EN011) is named in one documented claim (his letter of 3 May 1692 inviting Locke to Cambridge), so HR-EN011 is listed in `identity.historical_mentions`; the modern episode does not name him.
- What was verified and what was not. His lifelong cough from about 1670, his intolerance of London's coal smoke, his move to Oates in the spring of 1691, his letters about his lungs and breathing (1689 to 1704), the breathlessness lying flat of January 1698, the sore legs and deafness of his last years, the leg swelling and increasing breathlessness of 1704, and his death are D, from the Dictionary of National Biography, the Stanford Encyclopedia of Philosophy, Williams (2006), and Fox Bourne's biography, which quotes his letters and Lady Masham's account; letters written in Latin are quoted in Fox Bourne's translation. The de Beer edition of the correspondence, Woolhouse's biography, Dewhurst's medical biography, Cohen's 1995 article, the Bodleian Locke manuscripts, and the 1932 Canadian Medical Association Journal article (a scanned image only) could not be read and are not cited. No medical notes in which Locke described his own illness were found; Fox Bourne states that the “Tussis” fragment contains no personal information, and the record says so.
- Corrections to the roster. The roster says that asthma and probable tuberculosis drove him into exile in the Netherlands for cleaner air. The sources read describe the exile of 1683 to 1689 as political, so the record does not say he went abroad for his health; his journey to Montpellier in 1675 is the documented health journey. The roster's “tuberculosis” is not supported: no source read diagnoses it; his father and brother died of “consumption”, recorded as family history, and Fox Bourne's view that care kept his cough from passing into consumption is R, possible (CLM-0019). The roster's “insomnia” and “political exile stress” were not found in the sources read and are left out.
- Asthma as a historical diagnosis. That he was “asthmatic” comes from modern secondary sources (the Stanford Encyclopedia and Williams), not from a physician of his time, and is recorded as R, probable (CLM-0018). Fox Bourne uses the word asthma only of the king. The breathlessness lying flat and the leg swelling of his last years are recorded as documented symptoms; the record proposes no historical diagnosis of heart failure or any cause of death, because no source read offers one.
- Presenting problem and diagnosis. The intake problem (R05.3) is a chronic cough with wheeze and breathlessness, resolved on March 26, 2026, when asthma with persistent airflow limitation is recorded. The diagnosis was chosen between asthma with persistent airflow limitation and COPD from non-tobacco exposures, and decided for asthma: onset in his late thirties, variation with season, cold, and smoke, a bronchodilator response of 380 mL (11 percent of predicted), FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, a raised IgE, a normal DLCO, and a CT without emphysema; the post-bronchodilator ratio below 0.70 and the lifelong exposures are why COPD was considered. The record follows GINA and GOLD in treating anyone with asthma features as asthma, with inhaled corticosteroid. The ICD-10-CM code is J45.40 (moderate persistent) because his pre-bronchodilator FEV1 of 62 percent predicted falls in the NAEPP moderate band; it is placed both_with_link to the documented history.
- Spirometry and results. All results are synthetic. Spirometry is interpreted with GLI Global race-neutral equations (ATS 2023) and the ERS/ATS 2022 bronchodilator criterion; the predicted values and lower limits were estimated for a man of 59 and 178 cm and are stated in each reference range. FEV1 percent predicted is coded with LOINC 20152-5 as measured before bronchodilator. The CT and chest X-ray are recorded as procedures with their findings, because their results are not numeric.
- Exposure and its modern form. The modern exposure (about 30 years in a large city near main roads, then open coal and wood fires in his rooms) echoes, without measuring, the coal smoke that he, Sydenham, and Lady Masham blamed for his cough (CLM-0007, CLM-0008). The exposure advice follows the ERS 2020 personal-strategies paper, the WHO 2021 air quality guidelines (PM2.5 5 ug/m3 annual, 15 ug/m3 24-hour, verified in the UK COMEAP table because the WHO pages show the values only as images), the AirNow AQI categories, and the EPA guide to air cleaners. The household that removes the open fires is synthetic and unnamed.
- Treatment choices. Albuterol alone for two weeks only, so the bronchodilator response could be measured before an inhaled corticosteroid; then medium-dose budesonide-formoterol as maintenance and reliever (GINA track 1, step 4) because asthma was very poorly controlled with low lung function; at twelve weeks, with an Asthma Control Test of 19, persistent airflow limitation, good adherence, and FeNO down to 22 ppb, add-on tiotropium (GINA step 5) rather than a higher corticosteroid dose; no biologic, because he has had no flares needing oral corticosteroids. Pulmonary rehabilitation improved his six-minute walk by 75 m.
- Tuberculosis and other exclusions. Because of a chronic cough and his family history of consumption, an interferon-gamma release assay and a chest X-ray are done and are negative. Alpha-1 antitrypsin deficiency (GOLD) and heart failure (NT-proBNP) are excluded at intake.
- Sick and preventive visits. The preventive visit is `preventive_adult` because he is 60; it gives influenza, COVID-19, and RSV vaccines (RSV recommended at 60 to 74 with chronic lung disease), defers zoster to the next visit at his request (given at the last visit), screens lipids (normal), records that he declined PSA screening after a shared decision, and documents advance care planning that names no real person. The sick visit is a common cold with a yellow-zone flare (peak flow 68 percent of best), managed by his action plan with extra budesonide-formoterol and no oral corticosteroid or antibiotic, with explicit thresholds for prednisolone and for emergency care; it echoes, without asserting, his documented autumn chest troubles.
- Focused visits. The three chronic-care follow-ups (two weeks, twelve weeks, and seven months after intake) are documented as focused visits on the CMID asthma and COPD monographs with GINA 2025, NAEPP 2020, GOLD 2025, the ERS/ATS 2022 and ATS 2023 lung-function statements, and the air-quality guidance: Asthma Control Test, inhaler technique, adherence and reliever use, exacerbation history, exposure review, smoking status, the action plan, and step assessment at every visit; spirometry and FeNO at diagnosis and three months; DLCO, alpha-1 antitrypsin, and imaging once; the six-minute walk before and after rehabilitation; comorbidity screening at diagnosis; vaccination status; and biologic candidacy recorded as not indicated. Two deviations are recorded as `deferred`, with outcome and corrective action, and no result was invented: the review within one week after the flare did not take place (no harm; peak flow recovered by the fifth day without prednisolone; the clinic now books a review within a week, by telephone if needed, written into the care plan as INT-009); and the twelve-week plan set the next full review after adding tiotropium at four months, beyond the protocol's 1 to 3 months; the preventive visit at 13 weeks reviewed his asthma but recorded no Asthma Control Test (no harm; well controlled; a control test is now recorded at any visit where asthma is reviewed).
- Consultation. The pulmonology referral and consultation (Ambrose Nwankwo-Fairfax, MD, a fictional consultant, on the day of the second visit) are S. The consultant confirms asthma with persistent airflow limitation rather than COPD, finds the CT indicated and shows its findings, recommends medium-dose budesonide-formoterol maintenance and reliever with add-on tiotropium if not controlled at three months, pulmonary rehabilitation, and the exposure plan; the record then shows each of these happening.
- Real people. Sydenham, Ashley (Shaftesbury), Lady Masham, Limborch, Boyle, Clarke, Somers, Peter King, Le Clerc, and Isaac Newton appear only in documented history claims. The modern episode names none of them and attributes no decision, statement, or health fact to them; the household he lives with and the friend he names as his health care agent are unnamed and synthetic. The family history of consumption in his father and brother is documented (CLM-0003) and is used only as family history.
- Primary clinician. Prudence Hartwell-Osei, MD, is cast as his primary care physician.
- John Locke died in 1704, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-10-22 Progress note 06 (C-CDA) | Review within one week after a flare | Within one week of any exacerbation | Missed: the one-week review planned at the sick visit was not booked because no slot was free, and no telephone check was arranged. No harm resulted: his diary shows the peak flow back above 400 L/min by the fifth day without prednisolone. Corrective action: the clinic now books a review within one week, by telephone if no slot is free, whenever he calls or is seen for a flare, and this is written into his care plan |
2026-10-22 Progress note 06 (C-CDA) | Review 1 to 3 months after a controller change, with an Asthma Control Test | 1 to 3 months after starting or changing controller treatment | Partly missed: the twelve-week plan set the full review with an Asthma Control Test at four months, beyond the protocol's 1 to 3 months. The preventive visit at 13 weeks reviewed his symptoms, reliever use, and side effects, but no Asthma Control Test was recorded until today. No harm: he was well controlled at that visit and today. Corrective action: an Asthma Control Test is recorded at any visit where asthma is reviewed |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-03-26 Progress note 02 (C-CDA) | Referral | Pulmonary rehabilitation | Ordered | Eight-week program starting next week |
Evidence to check
Retrospective claims (R)
| Claim | Statement | Certainty |
|---|
| CLM-0018 | Modern accounts describe him as asthmatic: the Stanford Encyclopedia of Philosophy states that he was asthmatic, and a 2006 history of medicine article that his health was blighted throughout life by asthma, which often incapacitated him for long periods. | probable |
| CLM-0019 | Fox Bourne judged that his cough was connected with disease in the lungs, and that probably only extreme care in treating himself had kept it from passing into a rapid consumption. | possible |
Sensitive claims
None.
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-03-12 | Total IgE | 186 [IU]/mL (high) | High |
| 2026-03-26 | FEV1 before bronchodilator | 2.11 L (low) | Low |
| 2026-03-26 | FEV1/FVC before bronchodilator | 0.57 (low) | Low |
| 2026-03-26 | FEV1 percent predicted (before bronchodilator) | 62% (low) | Low |
| 2026-03-26 | FEV1 after bronchodilator | 2.49 L (low) | Low |
| 2026-03-26 | FEV1/FVC after bronchodilator | 0.62 (low) | Low |
| 2026-03-26 | FeNO | 41 [ppb] (high) | High |
| 2026-03-26 | Six-minute walk distance | 430 m (low) | Low |
| 2026-06-18 | FEV1 before bronchodilator | 2.46 L (low) | Low |
| 2026-06-18 | FEV1 percent predicted (before bronchodilator) | 73% (low) | Low |
| 2026-06-18 | FEV1 after bronchodilator | 2.58 L (low) | Low |
| 2026-06-18 | FEV1/FVC after bronchodilator | 0.63 (low) | Low |
| 2026-10-08 | Peak expiratory flow | 300 L/min (low) | Low |